自 1997 年起,凯理斯帮助全球生物制药公司和 CRO 成功利用医学影像开展临床试验。We offer a full range of imaging services and deliver therapeutically aligned value that allows you to best assess the safety, efficacy, and effectiveness of your compounds, time after time.
Whether you’re in early phase development looking to partner, planning to take your compound through regulatory approval, or even seeking breakthrough therapy designation / approval, lean on Calyx’s 25+ years’ experience and benefit from a tailored core imaging strategy proven to meet your clinical development objectives.